A very conclusive study, done in human DN and covering several in vivo criteria, has been performed by Li et al. They demonstrate, with immunhistochemical stainings, a podocyte-specific attenuation of nephrin and ZO-1 as well as an enhancement of the expression of desmin, MMP9, and FSP1 [35]. The gene discussed is DES; the disease is liver dysplastic nodule.